Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Gene Expression|January 1, 1995
Signal transduction and activation of gene transcription by interferonsK C Gilmour, N C ReichProceedings of the National Academy of Sciences of the United States of America|July 19, 1994
Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factorsK C Gilmour, N C ReichProceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytesK C Gilmour, R Pine, N C ReichCell|July 26, 1996
The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyteT Crompton, K C Gilmour, M J OwenClinical and Experimental Immunology|February 10, 2011
Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and managementC Gholam, S Grigoriadou, K C Gilmour, et al.Journal of Inherited Metabolic Disease|March 10, 2009
Type II Gaucher disease manifesting as haemophagocytic lymphohistiocytosisL-R Sharpe, P Ancliff, P Amrolia, et al.Clinical and Experimental Immunology|October 5, 2017
A comparison of TRECs and flow cytometry for naive T cell quantificationS P Adams, S Kricke, E Ralph, et al.Blood|July 27, 2001
Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiencyK C Gilmour, H Fujii, T Cranston, et al.Molecular Pathology : MP|September 30, 2003
Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgMK C Gilmour, D Walshe, S Heath, et al.Clinical and Experimental Immunology|October 27, 2001
X-linked lymphoproliferative disease: three atypical casesK Nistala, K C Gilmour, T Cranston, et al.Pageof 2